Release Date: October 8, 2025
Expiration Date: October 8, 2026
Activity Overview
Oncology health care professionals who treat patients with lung cancer have an increasing array of diagnostic and therapeutic tools at their disposal. In this online, on-demand virtual symposium, renowned experts in lung cancer distill the latest data on targeted agents, immunotherapy, surgery, and radiation oncology for the management of lung cancer.
This educational activity is an archive of the live symposium held on July 25 and 26, 2025.
Target Audience
This educational activity is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of lung cancer are also invited to attend.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Examine the role of biomarkers and testing strategies in optimizing and personalizing treatment selection in patients with thoracic malignancies.
- Assess the implications of recent clinical trial evidence as well as ongoing trials concerning the management of patients with thoracic malignancies.
- Determine approaches to integrating monotherapy and combination immunotherapeutic approaches in the management of patients with thoracic malignancies.
- Create strategies to integrate targeted and cytotoxic strategies for the management of patients with thoracic malignancies.
- Outline approaches to address disparities in care for patients with thoracic malignancies.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here